SAN ANTONIO, Tx - Cancer patients need a lot of drugs—immunotherapies, chemotherapies, and anti-infectives. But new research at ObesityWeek® on Nov. 3, 2024, shows clinicians may not have all the ...

A drug against fungal infections in cancer patients can last twice as long in people with obesity, and may make chemotherapy ...

Persona™ Nutrition, a pioneer in subscription-based personalized vitamins and supplements, today launches its white-labeling ...

The Daily Results line is designed for retailers who want to offer national brand equivalent products but have not developed ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

The gene therapy improved annualized bleed rates, though a handful of study participants resumed factor IX prophylaxis.

Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term ...

Organon (NYSE:OGN) projected a roughly 75 basis-point headwind to the company’s 2025 EBITDA margin on Tuesday after the FDA delayed a potential label expansion for its skin disorder therapy VTAMA ...

A collaboration of researchers led by Emory University Rollins School of Public Health, Atlanta, is urging caution when prescribing off-label glucose-lowering drugs to individuals with type 1 ...

The new policy follows weeks of back-and-forth complaints about Islamophobia and antisemitism on the platform.